DEC 2 BPAC

Background Analysis: US FDA Advisory Committee to Review Blood Donor Policies Involving MSM, Chikungunya Virus Infections, and MERS-CoV – DEC 2-3, 2014 (BPAC)

The US FDA has scheduled a meeting of the Blood Products Advisory Committee (BPAC) for Tuesday and Wednesday, December 2–3, 2014. On December 2nd the committee will hear scientific data related to reconsideration of the current blood donor deferral policy for men who have had sex with another man (MSM) even one time since 1977. The Committee will be presented with an update on the November 13, 2014, meeting of the US Department of Health and Human Services (DHHS) Advisory Committee on Blood and Tissue Safety and Availability, where the MSM blood donor deferral policy will be discussed. In the afternoon, an informational presentation will be made regarding the emergence of chikungunya virus infections in the Western Hemisphere and potential implications for blood transfusion safety. The Committee will also hear an informational presentation on the first survey of the Rapid Donor Surveillance (RapidDOS) project on Middle Eastern Respiratory Syndrome coronavirus (MERS-CoV).

See the SAC Tracker Report